On Friday, Lowe’s Companies, Inc. (NYSE:LOW)’s shares declined -1.88% to $67.80.
Z-Wave Alliance, a global consortium of over 325 member companies supporting the Z-Wave wireless IoT standard, is excited to declare that home improvement company Lowe’s has joined its membership with the Iris by Lowe’s smart home solution. A retail destination for a variety Z-Wave smart home devices, Lowe’s joins a diverse and growing membership of companies committed to the Z-Wave brand.
Launched in July 2012, Iris by Lowe’s is a smart home solution created to monitor and control virtually everything in the home anytime, anywhere, from a computer, smart phone or tablet. Lowe’s was among the first companies to target the mass consumer market with a broad home automation solution and to introduce a truly open platform, with the customer support that consumers have come to trust from Lowe’s.
The addition of Iris by Lowe’s to the Z-Wave Alliance comes after a huge growth period for the group. In the first half of 2015, Alliance membership grew an astounding 20 percent in the first half of 2015, adding more than 60 new members to the organization’s roster. Z-Wave has led the market in interoperable smart devices for the home since the first Z-Wave product was certified in 2004. With 40 million IoT devices in the market recently, Z-Wave has proven to be a leader in the smart home, lifestyle security and IoT industries.
Lowes Companies, Inc. operates as a home improvement retailer. The company offers products for maintenance, repair, remodeling, and home decorating. It provides home improvement products under the categories of kitchens and appliances; lumber and building materials; tools and hardware; fashion fixtures; rough plumbing and electrical; lawn and garden; seasonal living; paint; home fashions; storage and cleaning; flooring; millwork; and outdoor power equipment.
PG&E Corporation (NYSE:PCG)’s shares dropped -1.45% to $47.60.
For the fifth time, Pacific Gas and Electric Co. (PG&E) was recognized as one of the best companies for Latinas to work for in the United States by LATINA Style Magazine. This was the 18th annual LATINA Style 50 Report, considered the most respected evaluation of corporate America’s policies and opportunities for Latinas in the workplace.
Companies acknowledged in the report were evaluated on matters LATINA Style Magazine readers identified as most important to them in the workplace. Principal areas of review comprised of the number of Latina executives, retention, mentoring, educational opportunities, alternative work policies, employee benefits, women’s issues, job retraining, affinity groups and Hispanic relations.
As of Dec. 31, 2014, Latinas comprise 5.1 percent (1,128) of PG&E’s total employees. The number of Latina employees at PG&E has steadily raised over the last five years. As of Dec. 31, 2014, Latinas account for 18.2 percent of PG&E’s female employees. This is an enhance of nearly 2 percent from 2010 (16.7, 932).
PG&E Corporation, through its partner, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California. The company’s electricity distribution network comprises of 141,700 circuit miles of electric distribution lines, 55 transmission switching substations, and 603 distribution substations; and electricity transmission network comprises 18,100 circuit miles of interconnected transmission lines and 91 electric transmission substations. Its natural gas system comprises of about 42,700 miles of distribution pipelines, about 6,400 miles of backbone and local transmission pipelines, and various storage facilities.
At the end of Friday’s trade, Horizon Pharma PLC (NASDAQ:HZNP)‘s shares dipped 29.40% to $-0.71.
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, recently declared it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 14/705,606 (U.S. publication number 2015-0231262), entitled “Diclofenac Topical Formulation” that covers Horizon’s U.S. approved product PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%).
This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are accomplished. The U.S. patent planned to issue from this application will expire October 17, 2027. After issuance, Horizon plans to list the patent in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. The company offers ACTIMMUNE for reducing the frequency and severity of serious infections associated with chronic granulomatous disease; DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications; PENNSAID for the treatment of pain of OA of the knee; and VIMOVO, a proprietary fixed-dose multi-layer delayed-release tablet for the relief of the signs and symptoms of OA, RA, and ankylosing spondylitis (AS).
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), ended its Friday’s trading session with -1.14% loss, and closed at $13.00.
Villa Medical Clinic in Newburg, Ore., selected Allscripts (MDRX) Chronic Care Administration (CCM) Program to establish ongoing monthly outreach to hundreds of patients who suffer from two or more chronic conditions without adding staff or increasing workloads for current employees.
Villa Medical Center has served its community for more than 50 years and presently provides care services with one physician, three physician assistants and a team of nurses and support staff. The practice sought a way to simplify the rollout of care for patients with chronic conditions through the Centers for Medicare & Medicaid services (CMS) reimbursement program. The practice is in the process of transitioning to Allscripts Professional EHR(TM) from which it will be able to identify Medicare and Medicaid patients with chronic conditions who could benefit from raised care.
Allscripts Healthcare Solutions, Inc. provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The Clinical and Financial Solutions segment provides integrated clinical software applications, financial and information solutions, and related installation and maintenance services, counting EHR related software, financial and practice administration software, related installation and training services, and electronic claims administration services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
